Disease Trends and Mortality From Invasive Pneumococcal Disease: A Long-Term Population-Based Study
Clinical Infectious Diseases · 2025
DOI: 10.1093/cid/ciaf670 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Infectious Diseases, 2025. Verfasst von Hörður Tryggvi Bragason und 4 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, School of Health Sciences, University of Iceland, Reykjavik, Iceland. Hauptthemen laut MEDLINE: Pneumococcal Infections, Streptococcus pneumoniae. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Icelandic Centre for Research, National University Hospital of Iceland, The Scandinavian Society for Antimicrobial Chemotherapy Foundation.
Abstract (Originalsprache)
Background
Streptococcus pneumoniae is a major global cause of invasive pneumococcal disease (IPD) and death. Introduction of the pneumococcal conjugate vaccine (PCV) has led to substantial declines in IPD incidence in many countries. Long-term, population-based studies on mortality trends among survivors of acute IPD are scarce.
Methods
Data encompassing all individuals diagnosed with IPD in Iceland from 1975 to 2020 were analyzed. Diagnosis required a positive blood or cerebrospinal fluid culture. 30-day and 5-year mortality rates were assessed across 3 decades (1985–2014), adjusting for multiple covariates. Additionally, age-standardized all-cause mortality rates were compared between patients with IPD and the general population.
Results
The cohort included 1463 patients of all ages. Invasive pneumococcal disease incidence peaked in 1995–2004 and declined significantly thereafter (P < .001). Serotype 7F was the most prevalent. No improvement in short-term mortality at 30 days was detected over time (P = .98). A modest improvement in 5-year mortality was observed, although this did not reach statistical significance (P = .076). Even when early deaths were excluded, the ASR for all-cause mortality in patients with IPD was 2.6 times higher than in the general population (0.021 vs 0.008 per person-year).
Conclusions
IPD incidence declined substantially over time, particularly following the introduction of the 10-valent PCV in 2011, yet short-term mortality remained unchanged. A modest improvement in long-term mortality was observed, possibly reflecting advances in chronic disease management. Invasive pneumococcal disease survivors face significantly elevated long-term mortality compared to the general population. Targeted interventions are needed to reduce short-term mortality associated with IPD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Medicine, School of Health Sciences, University of Iceland, Reykjavik, Iceland.
- Department of Infectious Diseases, Landspitali-the National University Hospital of Iceland, Reykjavik, Iceland.
- Department of Science, Landspitali-the National University Hospital of Iceland, Reykjavik, Iceland.
ORCID-Profile: Kristján Godsk Rögnvaldsson, Ubaldo Benitez Hernandez, Magnús Gottfreðsson
Förderung
- Icelandic Centre for Research
- National University Hospital of Iceland
- The Scandinavian Society for Antimicrobial Chemotherapy Foundation
- The University of Iceland Research
Zitieren
APA
Bragason, H. T., Rögnvaldsson, K. G., Hernandez, U. B., Erlendsdóttir, H., & Gottfreðsson, M. (2025). Disease Trends and Mortality From Invasive Pneumococcal Disease: A Long-Term Population-Based Study. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciaf670
Vancouver
Bragason HT, Rögnvaldsson KG, Hernandez UB, Erlendsdóttir H, Gottfreðsson M. Disease Trends and Mortality From Invasive Pneumococcal Disease: A Long-Term Population-Based Study. Clinical Infectious Diseases. 2025. doi:10.1093/cid/ciaf670
BibTeX
@article{Bragason2025,
author = {Bragason, Hörður Tryggvi and Rögnvaldsson, Kristján Godsk and Hernandez, Ubaldo Benitez and Erlendsdóttir, Helga and Gottfreðsson, Magnús},
title = {Disease Trends and Mortality From Invasive Pneumococcal Disease: A Long-Term Population-Based Study},
journal = {Clinical Infectious Diseases},
year = {2025},
doi = {10.1093/cid/ciaf670}
}
EUVIMED